Atlantic Health System
atlantichealth.orgTotal trials
60
Active
8
Phase 3
0
Total enrollment
7,964
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Nitrofurantoin | — | — | — | — | — | 1 | |
| NaF PET-CT | — | — | — | — | — | 1 | |
| Methenamine Hippurate 1g BD | — | — | — | — | — | 1 |
Next readouts
- 2024-08-16
- 2025-06-01
- 2027-07-30
Top conditions
- Pelvic Organ Prolapse11
- Urinary Incontinence4
- Vaginal Discharge3
- Mesh Erosion2
- Stress Urinary Incontinence2
- Mitral Regurgitation2
- Voiding Disorders1
- Overactive Bladder1
Frequently asked questions about Atlantic Health System
- How many clinical trials does Atlantic Health System have on ClinicalTrials.gov?
- Atlantic Health System is listed as the lead sponsor on 60 clinical trials in ClinicalTrials.gov, 8 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Atlantic Health System's trials are in Phase 3?
- 0 of Atlantic Health System's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Atlantic Health System focus on?
- Atlantic Health System's most-studied conditions on ClinicalTrials.gov are Pelvic Organ Prolapse, Urinary Incontinence, Vaginal Discharge, Mesh Erosion, Stress Urinary Incontinence.
- When are Atlantic Health System's next clinical trial readouts?
- Atlantic Health System has 3 upcoming primary-completion readouts tracked here; the soonest is “Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA”, expected around 2024-08-16.